Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Body Mass Index of Patients Under Treatment with SSRIs
IRCT20140102016035N3Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metformin in obesity, major depressive disorder (MDD) and anxiety disorder, sponsored by Guilan University of Medical Sciences. Started Jul 2019; status: completed.
02
Drugs
metformin
03
Conditions
obesitymajor depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on IRCT20140102016035N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140102016035N3.